Effects of tauopathy on the morphological properties of fan and stellate cells in the entorhinal cortex of the P301S mutant mouse model by Fowler, Michael
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2017
Effects of tauopathy on the
morphological properties of fan and
stellate cells in the entorhinal
cortex of the P301S mutant mouse
model
https://hdl.handle.net/2144/23807
Boston University
   
BOSTON UNIVERSITY 
 
SCHOOL OF MEDICINE 
 
 
 
 
 
Thesis 
 
 
 
 
 
EFFECTS OF TAUOPATHY ON THE MORPHOLOGICAL PROPERTIES OF 
FAN AND STELLATE CELLS IN THE ENTORHINAL CORTEX OF THE P301S 
MUTANT MOUSE MODEL 
 
 
 
by 
 
 
 
 
MICHAEL FOWLER 
 
B.S., Marquette University, 2011 
 
 
 
 
 
 
Submitted in partial fulfillment of the 
 
requirements for the degree of 
 
Master of Science 
 
2017  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
© 2017 by 
 MICHAEL FOWLER 
 All rights reserved  
   
Approved by 
 
 
 
 
First Reader   
 Jennifer Luebke, Ph.D. 
 Professor of Anatomy and Neurobiology 
 
 
Second Reader   
 Matthew D. Layne, Ph.D. 
 Associate Professor of Biochemistry 
 
 
 
 
  iv 
ACKNOWLEDGMENTS 
 
 I would like to thank my family, my mentors Dr. Luebke, Dr. Medalla, and Dr. 
Layne, and all of the friends I have made over the past two years, both from the Luebke 
lab as well as the classmates in my program. The support and friendships I have made is 
more valuable than any degree I could be awarded. I am truly blessed to have met each 
and every one of these individuals, and I know that they have helped me become a better 
individual. 
  
  v 
EFFECTS OF TAUOPATHY ON THE MORPHOLOGICAL PROPERTIES OF 
FAN AND STELLATE CELLS IN THE ENTORHINAL CORTEX OF THE P301S 
MUTANT MOUSE MODEL 
MICHAEL FOWLER 
ABSTRACT 
 Neurodegenerative diseases generally correlate with age; as the US population’s 
average age increases, neurodegenerative ailments will contribute a greater burden on the 
health care system. One of the most prevalent, Alzheimer’s disease, is known to associate 
with tau proteins with evidence suggestive that abnormal function may initiate 
neurodegeneration. The entorhinal cortex is one of the earliest regions found to exhibit 
neuronal atrophy in Alzheimer’s disease. This study analyzed two major neuron types in 
the entorhinal cortex, fan cells and stellate cells, using the P301S mouse model for 
tauopathy. Laser-scanning confocal microscopy and software were used to reconstruct 
and analyze dendrite morphology between the two neuron types. Our results found that 
stellate cells of transgenic mice exhibited dendritic atrophy, with decreases in 
morphological parameters such as dendritic length, dendritic complexity, and number of 
primary dendrites in comparison to wild-type stellate cells. On the other hand, fan cells of 
transgenic mice did not show decreases in these parameters. Instead, fan cells of 
transgenic mice showed increases in surface area and volume in a convex hull model, as 
well as an increase in total Sholl radius from soma in comparison to wild type fan cells. 
These results suggest that neurons may respond differently to tauopathic stress. 
Additionally, noting distinct morphological differences between wild type fan cells and 
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stellate cells, such as stellate cells having greater spine density and basal dendritic 
extensions, our data hints that morphological characteristics may predict susceptibility to 
pathogenic effects of tau.     
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INTRODUCTION 
Overview of Neurodegenerative Diseases 
Neurodegenerative diseases in a general sense are ailments that cause nervous 
tissue to degrade, specifically by causing the debilitation and death of neurons. As 
neurons are incapable of replication beyond early development and generally are not able 
to be replaced, damage from neurodegenerative diseases is typically irreversible. 
Examples of neurodegenerative diseases include Alzheimer’s Disease (AD), Parkinson’s 
disease, and Huntington’s disease. 
Overall, the incidence as well as severity of neurodegenerative diseases such as 
AD have been found to be correlated with age (Hebert et al. 2003). Because of the 
expected rise in age of the United States’ population (Anderson et al. 2012), overall 
healthcare costs for neurodegenerative diseases is expected to increase (Geldmacher, 
2012). For example, over the next 50 years, the prevalence of AD is expected to increase 
by a factor of three in the US population; additionally, the number of persons aged 85 or 
more will be expected to quadruple by this same time frame (Hebert et al. 2003). 
Ailments like AD can be expensive to manage as most individuals require full-time care, 
with Geldmacher, 2002 noting that dementia caused from AD results in the third most 
costly illness in the United States. Additionally, many neurodegenerative diseases can 
have a relatively lengthy duration creating a scenario that can strongly burden the public 
healthcare infrastructure (Dharmarajan and Gunturu, 2009). Beyond financial costs 
though, the toll that neurodegenerative diseases can take on the sufferer are immense: one 
survey of caregivers found that patients exhibited anxiety (63.4%), depression (63.4%), 
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hopelessness (35.2%), feelings of worthlessness (29.7%), and tearfulness (27.1%) 
(Schulz et al. 2008). Caregivers themselves also showed moderate levels of depressive 
symptoms (Schulz et al. 2008).  
Tauopathies are a subset of neurodegenerative disease in which the primary 
pathology of the disease is caused by misfolding or hyperphosphorylation of the protein 
tau (Lee and Leugers, 2012). The earliest and most prevalent symptom that individuals 
with neurodegenerative diseases related to tauopathies suffer from is increasing memory 
loss (Meier et al. 2016). Symptoms can range, however, from dementia to movement 
disorders (Xu et al. 2014). While studying the effects of tauopathy on the hippocampus in 
the P301S mouse model—a genotype for frontotemporal dementia with parkinsonism 
linked to chromosome 17 (FTDP-17), useful in repeating human symptoms of tauopathy 
(Takeuchi et al. 2011)—Xu et al. 2014 noted that visuospatial memory skills deteriorated 
first; this was then followed by a lack of exploring activity and finally locomotor 
dysfunction. During the period where only visuospatial memory skills had deteriorated, 
only soluble tau was found present in neurons, with no neuron cell loss being observed at 
this point (Xu et al. 2014). This differed later in the course of the disease when locomotor 
dysfunction was noted: at this point, insoluble tau was observed in addition to soluble 
forms (Xu et al. 2014).  
One challenge with neurodegenerative disorders is that they can be difficult to 
diagnose as symptoms may overlap with other ailments (Gómez-Río et al. 2016). 
Additionally, damage may occur to nervous tissue before symptoms become noticeable. 
For example, in AD, full clinical symptoms do not develop until after pathological effects 
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in the brain, such as neuronal atrophy, have already taken place (deToldeo-Morrell et al. 
2007). In many cases, early symptoms of AD are identical to other ailments, making 
diagnosis even more difficult. For example, Mild Cognitive Impairment (MCI) which is a 
general cognitive ailment, impairs individuals mildly enough so as to not interfere with 
allowing them to conduct normal activities, but cognitively impairs the individual to a 
greater extent when age is taken into account (Ritchie et al. 2001). Many times these 
symptoms overlap with mild AD, and, making the situation even more complicated, MCI 
is known to progress to AD in some patients (Peterson et al. 1999). 
Overview of the Entorhinal Cortex 
The symptoms for a specific neurodegenerative disease relates to the region of the 
brain being impacted. For example, in regards to AD, at the earliest stages of the disease, 
regions of the entorhinal cortex and hippocampal formation are impacted (deToldeo-
Morrell et al. 2007). The hippocampus, an important region for assimilating information 
before memory formation can occur has been shown in certain tauopathies to exhibit 
atrophy and structural alterations, in line with many studies of tauopathies negatively 
impacting memory (Xu et al. 2014). For AD specifically, one of the earliest regions of the 
brain to be impacted is the entorhinal cortex (EC) which provides the main afferent input 
into the hippocampus (deToledo-Morrell et al. 2007).  
Structure of the Entorhinal Cortex 
The entorhinal cortex (EC) is part of a larger functional unit: the hippocampal 
formation, which includes the EC, dentate gyrus, hippocampus, subiculum, 
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presubiculum, and parasubiculum (Li and Pleasure, 2013), each of which can be 
visualized in three different organisms in Figure 1. In mice, the EC is located in the 
caudal section of the temporal lobe, unlike in primates where it is located rostrally. The 
EC is divided into two sections: the lateral entorhinal cortex (LEC) and the medial 
entorhinal cortex (MEC). From a morphological view, a major difference between the 
LEC and MEC is found in layer II where the MEC appears more uniform in appearance 
compared to the LEC which appears more heterogeneous; additionally, the MEC has a 
more noticeable lamina dissecans compared to the LEC (Burwell and Agster, 2008).  
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Figure 1. Location of the Entorhinal Cortex Across Three Species (Burwell and 
Agster, 2008). Shown are representations of the entorhinal cortex as well as surrounding 
regions of the human (a,d), monkey (b,e), and rodent (c,f) brain. The top panels show a 
lateral view of the main structures, whereas the lower panels show an unfolded view of 
the cortical structure. cs, collateral sulcus; EC, entorhinal cortex; HF, hippocampal 
formation; LEA, lateral entorhinal area; MEA, medial entorhinal area; ParaS, 
parasubiculum; PER, perhinal cortex; PH, parahippocampus; POR, postrhinal cortex; rs, 
rhinal sulcus; TF, thalamic fasciculus; TH, thalamus 
 
Interconnectivity to Surrounding Neural Network for the Entorhinal Cortex 
The EC is complex with regard to its anatomical connections (Burwell and 
Agster, 2008). Functionally, the EC is significant in that its axons comprise the major 
excitatory input to the apical dendrites of neurons in the hippocampus via the performant 
path, specifically regions CA1 to CA4 and the dentate gyrus (Bielle and Garel, 2013). 
Regarding layers, layer II neurons from the EC connect with granule cells of the dentate 
gyrus and CA3, while layer III neurons from the EC connect to the CA1 and subiculum 
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(Tahvildari and Alonso, 2005). Additionally, the EC also acts as an end point from 
signaling originating from the hippocampal formation (Craig and Commins, 2006). For 
example, the subiculum is noted to relay back to the EC, before the signaling is 
eventually relayed back to the cortex (Tahvildari and Alonso, 2005). Overall, the general 
layout of the hippocampal formation is designed such that most components, including 
the EC, relay their outputs to the subiculum, which subsequently connects with the 
neocortex (Craig and Commins, 2006).  
Physiological Function and Significance of the Entorhinal Cortex 
Being part of the mesial temporal lobe memory system, the EC is critical in 
receiving sensory information from the neocortex, and then relaying that information to 
the hippocampus via the performant pathway (deToledo-Morrell et al. 2007). The EC 
functions by relaying sensory information to different regions of the hippocampal 
formation; additionally, it plays a role in organizing spatial information (Burwell and 
Agster, 2008). The LEC is crucial in transferring information regarding distinct objects or 
items from the perihinal cortex to the hippocampus, while the MEC is critical in relaying 
both spatial and contextual information from the postrhinal cortex to the hippocampus 
(Agster and Burwell, 2013). Additionally, the LEC has long been known for its role of 
relaying olfactory information from the lateral olfactory tract to the dentate gyrus (Wilson 
and Steward, 1978). When this information arrives at the dentate gyrus and CA3 regions, 
information is then combined together to allow for both time and spatial inputs to be 
provided with an episodic memory (Knierim et al. 2006). Analyses in mice have shown 
that inactivating either the MEC or LEC will create deficiencies in episodic task 
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performance, but in different ways. A study by Yoo and Lee, 2017 showed that when the 
MEC was inactivated, mice were not capable of making decisions when provided visual 
signals, though inactivation of the LEC did not result in this observation. On the other 
hand, when a specific task was required, the LEC was shown to be vital in performing 
this function (Yoo and Lee, 2017). When the entire EC is impaired, as was done in a 
study by Parron et al. 2004, it was shown that the animal was incapable of performing 
visuospatial tasks when relying on distal landmarks, but was successful in completing the 
task if utilizing proximal landmarks. This would suggest that when processing spatial 
information, additional neural networks beyond the EC are employed when synthesizing 
visual information from other than distal landmarks (Parron et al. 2004). 
Neurodegeneration in the Entorhinal Cortex 
In many neurodegenerative diseases where memory function is impaired, such as 
AD or MCI, post mortem reports have shown the EC as well as the regions around the EC 
to have pathological properties, including atrophy via MRI analysis (deToldeo-Morrell et 
al. 2007). In addition to these pathological observations, the overall physical size of the 
EC can be a useful predictor in likelihood of conversion of MCI to AD; deToledo-
Morrell et al. 2007 noted that a roughly 0.1 unit decrease in EC volume related to the 
doubling of odds for conversion of MCI to AD to occur. The decrease in volume and not 
simply neuron count suggests a decrease in neuropil and synapses (Gómez-Isla et al. 
1996).  
In total, roughly 7 million neurons exist in the human EC; this value remains 
relatively constant throughout adulthood, but is found to be reduced significantly at the 
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earliest stages of neurodegenerative diseases such as AD to such a great extent that 
neuronal loss must occur before clinical symptoms of the disease become apparent 
(Gómez-Isla et al. 1996). Although all layers of the EC eventually become affected, 
neuron loss occurs earliest and most predominantly in the superficial cortical layers of II 
and IV, while the deeper cortical layers (V, VI) and layers I and III only become 
impacted at a more advanced stage of the disease (Romito-DiGiacomo et al. 2007; 
Gómez-Isla et al. 1996). In addition to individuals with AD, MCI has been shown to 
cause significant atrophy and reduction of volume in layer II, with the degree of neuronal 
loss correlating to diminishment on performance of clinical tests for declarative memory 
(Kordower et al. 2001). When analyzing the LEC and MEC separately, studies have 
shown the LEC to be more vulnerable to neurodegeneration compared with the MEC, and 
is more likely to exhibit overall pathological features at the earliest instance of AD (Khan 
et al. 2014). In the study by Khan et al. 2014, it was noted that basal metabolic rates, 
measured by cerebral blood flow, were significantly higher in the LEC compared to other 
surrounding regions of the brain, including the MEC, suggestive that metabolic rates 
could influence vulnerability for preclinical regions where neurodegeneration begins. Of 
all symptoms, evidence suggests then that the earliest should derive from 
neurodegenerative compromise of the LEC, making the anterior pathway uniquely 
vulnerable for early stage effects of AD (Klein et al. 2016). As was previously 
mentioned, olfaction is linked to the LEC; therefore, it is of interest to note that AD-
related olfactory dysfunction is an early symptom the disease (Wesson et al. 2010). 
Wesson et al. 2010 found that not only was there a correlation between the degree and 
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incidence of olfactory symptoms, but also non-fibrillar amyloid (A) deposition, a 
pathogenic manifestation of AD, was found in the olfactory bulb before being detected in 
any other region of the brain. Additionally, there is other evidence that pathological 
activity in the LEC precedes the MEC. For example, the LEC was found to have a greater 
density of pathological amyloid plaques as well as develop the plaques earlier than the 
MEC (Klein et al. 2016). This suggested greater physiological disruption of the LEC as 
the greater density of plaques correlated with a decrease in both frequency and power of 
gamma oscillation measurements relative to the MEC, significant as gamma oscillations 
act as a gauge for measuring information transfer (Klein et al. 2016).  
Cells of the Entorhinal Cortex 
When comparing layer II neurons of the LEC and MEC, it was found that neurons 
were distinctly different in terms of morphological and electrophysiological properties 
(Tahvildari and Alonso, 2005). On the other hand, morphological and 
electrophysiological properties were found to be very similar when comparing layer III 
neurons of the LEC and MEC (Tahvildari and Alonso, 2005). The stellate cell (SC) was 
the predominant type of neuron when examining layer II of the MEC, comprising roughly 
69 percent of neurons surveyed in one study (Alonso and Kirk, 1993). On the other hand, 
when examining layer II of the LEC, the predominant neuron was the fan cell (FC) 
(Tahvildari and Alonso, 2005). Both SCs and FCs were found to have a somewhat similar 
morphology, with both possessing several dendrites that extend through layers I and II of 
the EC for example (Marcantoni et al. 2014).  
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Major differences exist in terms of morphology between the two major cell types 
analyzed in this study. FCs possess multiple primary dendrites that are relatively thick 
and branch in both horizontal and ascending directions (Tahvildari and Alonso, 2005; 
Canto and Witter, 2012). This results in a shape that resembles a half-moon (or a fan) 
with the neuron’s base parallel to layer II (Tahvildari and Alonso, 2005; Canto and 
Witter, 2012). It should be noted that occasionally fan cells can possess scarce dendrites 
in the basal orientation; this should not prevent the neuron from being classified as a fan 
cell (Tahvildari and Alonso, 2005) (Figure 2). 
 
 
 
Figure 2: Pictorial representation of a fan cell (Tahvildari and Alonso, 2005). The 
image shows a fan cell’s morphological pattern of horizontal and apical dendrites as well 
as its location in the entorhinal cortex (layer II). Note that for the most part the neuron 
does not have a basal projection of dendrites, except for the faint dendrite highlighted by 
the arrow. Regardless of this anomaly, totality of evidence would still require this cell to 
be classified as a fan cell. 
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The most distinctive morphological characteristic of fan cells is their relative lack 
of descending dendrites heading towards layer III (Tahvildari and Alonso, 2005). The fan 
cell’s soma is polygonal in shape, and spine density amongst primary dendrites is 
relatively sparse (Tahvildari and Alonso, 2005; Canto and Witter, 2012). Primary 
dendrites for SCs, contrastingly, are equally spaced around the soma and branch 
extensively (Canto et al. 2008). Unlike FCs, SCs do possess basal dendrites, but they are 
relatively smaller compared to their apical dendrites (Canto et al. 2008). One highly 
characteristic feature about SCs is the strong amount of spines on their dendritic tree 
(Canto et al. 2008).  
 
 
 
Figure 3: Pictorial representation of a stellate cell (Alonso and Kirk, 1993; 
Tahvildari and Alonso, 2005). The image shows a stellate cell’s morphological pattern 
of dendrites branching in all directions, as well as its location in the entorhinal cortex 
(layer II). Note that unlike the fan cell, stellate cells do possess a basal projection of 
dendrites. 
Stellate 
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The electrophysiological properties the two cell types differ as well, with SCs 
firing at higher frequencies compared to FCs when injecting minimum current to generate 
an action potential (AP) (Marcantoni et al. 2014). Additionally, when providing 
maximum current, SCs were found to fire at higher rates with increased spike frequency 
adaptation compared to FCs (Marcantoni et al. 2014). When analyzing transgenic mice 
with early A accumulation, SC firing rate decreased to only a minor extent; while FC 
AP firing rate decreased significantly, suggestive that FCs may be more prone to 
negative effects caused by neurodegenerative tauopathies (Marcantoni et al. 2014). 
Marcantoni et al. 2014 notes that because FCs provide a major role in memory 
acquisition by acting as a major input to the hippocampus via the performant path, the 
observation that these neurons seem to be heavily impacted by mutant tau corresponds 
to clinical symptoms seen in early AD. 
Review of Spine Properties 
As one of the earliest sections to develop hyperphosphorylated tau accumulations 
in tauopathies, understanding the functionality of spines is critical for realizing the 
pathogenic significance that loss of spines can play in neurodegeneration. Functionally, 
dendritic spines are dynamic structures, with changes in shape as well as creation and 
destruction being shown to be essential for long-term memory and cognition (Kasai et al. 
2010). These alterations are governed by underlying actin filaments and have the 
capability of being morphologically altered in the timeframe of seconds (Hoffmann et al. 
2013; Testa et al. 2012). Through this morphological plasticity, neurons are capable of 
altering their synaptic interconnections (Hoffmann et al. 2013), and disorders in this 
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capability have been shown to lead to dementia and cognitive impairment (Kasai et al. 
2010). Larger spines may maintain old memories, while smaller spines that are newly 
formed appear to assist with new memories (Xu et al. 2014). Interestingly, the size or 
volume of the spine is proportional to both postsynaptic density and the AMPA receptor 
content (Hoffman et al. 2013). Spine density has also been shown to be important for 
cognitive ability as spine density has been shown to diminish in neurodegenerative 
diseases that negatively impact cognition (Xu et al. 2014). Cognitive function was able to 
be corrected in AD mice when spine density was increased to control, non-disease levels 
by removing intraneural Aβ plaques by administering HDAC inhibitor 4-phenylbutyrate, 
an agent which promotes protein folding thus preventing the accumulation of Aβ plaques 
(Ricobaraza et al. 2010).  
Normal Function of Tau 
Although tau protein plays an important role in many neurodegenerative ailments, it’s 
normal role is incredibly vital to the health of a neuron, as it acts to stabilize microtubules 
by helping assemble tubulin monomers, critical for maintaining the shape of the neuron 
(Buée et al. 2000). Additionally, as microtubules are pivotal for transport of both proteins 
and organelles, tau has a direct impact in the neuron’s capacity to perform this function 
(Buée et al. 2000). In total, six tau isoforms exist in homeostatic balance, all translated 
via alternative mRNA splicing from the MAPT gene located on chromosome 17q21.31 
(Spillantini et al. 2013). Generally tau is located in the axon of neurons (Binder et al. 
1985), but translocates to somatodendritic regions in pathogenic states (Xu et al. 2014). 
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Pathogenic Properties of Mutant Tau 
Overall, 48 tau mutations have been found to be linked to tauopathies (Zhang et 
al. 2016; Meier et al. 2016). Although multiple mutations in the tau gene have been 
shown to lead to specific cellular alterations, specific mutations can lead to diverse 
phenotypic results as well, suggestive that other genetic or epigenetic factors may be 
involved (Lee et al. 2001). In a study by Meier et al. 2016, it was found that protein 
synthesis was equally impaired in mice models for both normal wild-type (WT) tau and 
mutant tau variants (P301L and ∆K280), suggestive that non-mutated tau can have 
similar repercussions as mutated tau, diminishment in protein synthesis. 
Tau phosphorylation has been found to occur on roughly 25 serine and threonine 
residues located outside the region where tau binds to microtubules (Cohen et al. 2011), 
with half of these being phosphorylated via protein kinases such as members of the MAP 
kinase, cyclin-dependent kinase, and glycogen synthase kinase 3 families (Jin et al. 
2011). It is noted in Jin et al. 2011 that when tau comes into contact with natural 
oligomers such as Aβ dimers, it is possible to induce hyperphosphorylation, with this 
phenomenon occurring even when synthetic, non-AD related dimers were employed, 
though to a less significant extent.  
Neurofibrillary tangles (NFTs) form in a process of tau aggregation after tau has 
become hyperphosphorylated (Hoffmann et al. 2013). This both decreases its normal 
functional ability of binding to microtubules, as well as causes its subsequent transport to 
the somatodendritic region, where it assembles into filaments (Rizzu et al. 1999; 
Hoffmann et al. 2013). NFTs have long been shown to positively correlate to the degree 
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of neurodegeneration found in AD patients (Lee et al. 2001). In models where mice 
overexpressed WT human tau, however, NFTs were not found in cells before widespread 
neuron death occurred (Rocher et al. 2010). Additionally, NFTs do not necessarily lead to 
alterations in spine morphology, electrophysiological properties, or other characteristics 
noticed in neurons undergoing neurodegeneration (Rocher et al. 2010). In another study, 
it was noted that after transgenic tau was suppressed, memory function improved and 
neuron count stabilized, but NFTs continued to accumulate, suggestive that NFTs on their 
own do not cause cognitive or neuronal morphological symptoms for tauopathies 
(SantaCruz et al. 2005).  
Pathogenic Impact of Mutant Tau on Synapses 
Because synapses are located a relatively great distance from the neuron soma, 
and because they therefore rely on microtubule transport of materials, any disruption in 
this process can lead to negative effects regarding normal synaptic function (Yoshiyama 
et al. 2007). Excess mutant tau has been shown in studies to cause reduced binding to 
microtubules, increasing inefficiency in transport of materials from soma to synapse via 
axons (Zhang et al. 2004). In P301S mice where mutant tau levels are roughly five times 
endogenous tau levels, the mutated tau is not capable of efficiently binding to 
microtubules, leading to weakening of the microtubule polymer and reduction of tau in 
the at synapses (Roy et al. 2005).  
It is important to note that tau oligomers have been found to be neurotoxic 
whereas this finding does not necessarily apply to tau fibers or monomers (Lasagna-
Reeves et al. 2011). Specifically, tau oligomers negatively impact the function of 
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synapses by reducing levels of synaptic vesicle-associated proteins synaptophysin and 
septin-11 as well as negatively impact mitochondrial function by decreasing levels of 
NADH-ubiquinone oxidoreductase (Lasagna-Reeves et al. 2011). Tau oligomers have 
also been shown to activate caspase-9 resulting in apoptosis via the mitochondrial 
pathway (Lasagna-Reeves et al. 2011). Interestingly, oligomers of other proteins such as 
synuclein or insulin were not found to downregulate ribosomes, suggestive that tau has a 
specific means of interacting with ribosomes resulting in protein downregulation of 
products crucial for synaptic function (Meier et al. 2016).  
Pathogenic Impact of Mutant Tau on Axonal Transport 
Although tau is crucial in promoting microtubule stability, it can also have a 
negative impact on axonal transport through microtubule utilization. Stamer et al. 2002 
reported that tau inhibits transport of organelles such as peroxisomes and mitochondria as 
well as Golgi-derived vesicles. In part, this could make neurons more susceptible to 
oxidative stress, especially at distal portions from the cell soma if peroxisomes are not 
able to be transported to this region (Stamer et al. 2002). Stamer et al. 2002 notes that tau 
aggregation is not dependent for this phenomenon to occur; simply overexpression of 
normal tau is sufficient to negatively impact microtubule stabilization, leading to 
decrease in transport of necessary organelles and vesicles. Jin et al. 2011 noted similar 
findings, showing cytoskeletal abnormalities were inhibited if endogenous tau was 
knocked down, but found acceleration of cytoskeletal abnormalities when WT human tau 
was expressed. Decreasing tau was also shown to benefit axonal transport in AD models 
by preventing the negative inhibitory effect of Aβ oligomers on axonal transport (Vossel 
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et al. 2010). Finally, acetylation has been shown to prevent tau from binding to 
microtubules, thus negatively impacting microtubule stability. Evidence for this is that 
tau acetylation has been detected on four lysine residues, three of which comprise the 
microtubule-binding repeat region (Cohen et al. 2011). It has been suggested that tau 
phosphorylation could then allow for suitable protein structure in the MT-binding region 
to become acetylated, thus inhibiting tau’s capability of binding and stabilizing 
microtubules (Cohen et al. 2011). Other evidence regarding the critical role that 
acetylation plays in tau-microtubule association is related to the understanding that lysine 
deacetylase enzymes such as SIRT1 are significantly reduced in AD neurons and 
knocking down SIRT1 results in elevated levels of tau that are acetylated, suggestive that 
tau acetylation can play a negative role in tauopathies (Min et al. 2010). 
Pathogenic Impact of Tau on Protein Synthesis 
Because memory formation is dependent on protein synthesis, it follows that 
transcription or translation as well as errors in ribosomal function could play a role in 
symptom development in tauopathies. Ding et al. 2005 has noted that in AD patients, 
ribosomal function appears to be impaired in cortical regions, observing decreased rates 
of protein synthesis alongside decreased rRNA and tRNA levels as well as increased 
RNA oxidation. Interestingly, these findings occurred in individuals suffering only from 
MCI (which often precedes AD), suggestive that this decrease in protein synthesis is 
independent of later diagnostic findings common in AD such as NFTs or neuritic plaques 
(Ding et al. 2005). Although tau has been shown to interact with ribosomes, impairing 
protein synthesis by preventing translation factors from interacting with the ribosome, tau 
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has not been found to negatively interfere with elongation or initiation factors (Meier et 
al. 2016). Tau has also been shown to indirectly downregulate translation by causing 
chronic activation of the protein kinase RNA-like endoplasmic reticulum kinase (PERK) 
resulting in phosphorylation of the α subunit of eukaryotic translation initiation factor 2 
(Eif2α) (Meier et al. 2016; Marciniak et al. 2006). Because proteins necessary for proper 
synaptic function are also reduced (such as PSD-95), the pathogenicity of tau protein 
interaction with ribosomes can also negatively impact synaptic function (Meier et al. 
2016). 
Pathogenic Impact of Tau on Spines 
The majority of studies examining tauopathy mouse models have shown spine 
density to decrease (Hoffmann et al. 2013). However, as observed by Dickstein et al. 
2010, many studies showing alterations in spine density employed transgenic mutated 
tau, whereas when non-mutated tau is expressed, there appears to be no difference in 
spine density when comparing human tau (htau) to endogenous tau in WT mice. A 
review article by Luebke et al. 2010 noted a study of pyramidal cells, conducted with the 
rTg4510 mouse model—a transgenic mouse model causing overexpression of mutant 
tau—found a 30 percent reduction in spine density. For this study, an alteration in spine 
shape was noted: there was an overall decrease in mushroom and stubby spines, while 
simultaneously witnessing an increase in thin spines (Luebke et al. 2010). Additionally, it 
was noted that dendritic volume had a strong relationship with spine number, hinting that 
in order to preserve spine count, the neuron will adapt by lengthening its dendritic 
processes to increase spine volume. Functionally, having a higher percentage of large 
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spines in comparison to small spines allows for retention of long term memories while 
inhibiting formation of new memories (Xu et al. 2014). This reinforces findings which 
have shown that mice with tauopathies have difficulty learning new maze routines in 
comparison to WT mice (Xu et al. 2014). 
Loss of spine density may also be due to surrounding neuron loss. For example, 
Hoffmann et al. 2013 notes that tauopathies can cause loss of GABAergic interneurons in 
homozygous P301S Tau mice. Because these neural inputs would be inhibitory, to 
maintain homeostasis, a compensatory decrease in excitatory synapses may be required, 
consequently causing a decrease in overall spine density (Hoffmann et al. 2013).   
Spine shape has also been shown to be altered during tauopathies. After spine 
density decreases, remaining apical tuft dendrites of cortical layer V were found to be 
longer and have a larger head volume, resulting in an increase in mushroom spine 
percentage compared to thin spines (Hoffmann et al. 2013). Hoffman et al. 2013 argues 
that rationale for this increase in spine size during overall spine density loss would allow 
for surface area to remain closer to homeostatic levels, thus allowing for an attempt to 
increase synaptic connections. 
Hyperphosphorylated tau first accumulates in dendritic spines (Hoover et al. 
2010). Specifically, tau appears to be vulnerable for hyperphosphorylation on specific 
serine or threonine residues, and interestingly, if phosphorylation can be prevented, tau 
loses its capacity to relocate into dendritic spines (Hoover et al. 2010). If soluble 
hyperphosphorylated tau makes it to dendritic spines, however, the hyperphosphorylated 
tau impairs glutamate receptor trafficking and synaptic anchoring, thus leading to an 
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overall disruption of synaptic function by suppressing AMPAR-mediated synaptic 
responses as well as NMDA receptors (Hoover et al. 2010). It is important to note that 
although hyperphosphorylated tau has been shown to accumulate in dendritic spines in 
some cell populations such as CA3 hippocampal neurons, this is not always the case as 
there have been findings of htau being absent from spines despite accumulating 
elsewhere in the somatodendritic portion of neurons (Hoffmann et al. 2013). Reasoning 
for this may be due to the spine’s architecture: if the spine is supported by microtubules 
instead of actin filaments, this may facilitate htau accumulation due to its association with 
this cytoskeletal element as compared to actin (Hoffmann et al. 2013). It is interesting to 
note that protein kinases may play a role in the development of abnormal spine 
morphology and synapse deficiencies. A study by Tagawa et al. 2015 showed that 
inhibiting myristoylated alanine-rich C-kinases substrate (MARCKS) or by inhibiting the 
two protein kinases that are directly involved in phosphorylation of MARCKS, protein 
kinase C (PKC) and calmodulin-dependent kinase (CamKII), allowed for return of 
normal spine formation.  
Review of Stress Granules 
Stress granules (SGs) form when a cell comes under stress, such as what occurs in 
neurodegenerative tauopathies (Wolozin, 2014). SGs contain a large number of 
components: preinitiation factors, mRNA, mRNA-binding proteins (RBPs) such as TIA 
and TTP, proteins for mRNA metabolism such as G3BP, and signaling proteins 
(Kedersha and Anderson, 2007). In a nonpathogenic setting, SGs form through a complex 
process linked to some form of cellular stress, during which elongation initiation factor 
 21 
2 (eIF2) becomes phosphorylated and ribosomes along with initiation factors 
dissociate (Wolozin, 2012). Following this, RBPs bind to free, circulating mRNA, 
initiating the SG formation process; this process continues as more mRNA and RBPs 
accumulate, increasing the mass of the developing SG (Wolozin, 2012). eIF2 
phosphorylation acts as a key regulatory component for allowing RBPs to amass with 
other cellular components (Wolozin, 2012) as well as inhibiting translation initiation 
(Buchan and Parker, 2009). The overall effect from SG formation is that cellular 
resources are conserved for essential proteins by suppressing, silencing, or degrading 
non-essential protein translation (Wolozin, 2014) as well as allocating non-essential 
mRNA transcripts for utilization in SGs (Vanderweyde et al. 2013). SGs also play a role 
in determining whether stress is extreme enough for a cell to undergo apoptosis. SGs 
possess apoptotic regulatory proteins, effectively inhibiting these proteins from 
interacting with additional factors to promote apoptosis, thus inhibiting apoptosis in 
response to stress (Buchan and Parker, 2009). 
Overall, SG function appears to be protective; during stress, they seize mRNA 
that would not be useful for the cell, allowing protein translation that serves an overall 
protective role for the cell, such as inhibiting apoptosis, to be promoted (Vanderweyde et 
al. 2013). Additionally, via utilization of TTP—an RBP—SGs assist in degradation of 
mRNAs via nearby processing bodies (Vanderweyde et al. 2013). SGs are important in 
the synapse where they regulate production of synaptic proteins such as PSD-95 and 
GluR (Liu-Yesucevitz et al. 2011). Evidence suggests that SGs use cytoskeletal 
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microtubules to reach distance places in the cell such as the axonal synapse of a neuron 
(Knowles et al. 1996).  
Although SGs for the most part are beneficial to cells by helping cope with stress, 
pathogenic effects can precipitate when SGs endure for a lengthy, sustained time. For 
example, by creating an environment of compact, highly dense proteins, a suitable 
environment for forming oligomers and fibers may occur (Wolozin, 2012). Additionally, 
if SGs persist despite a lack of a stressful environment, negative impacts from sustained 
loss of normal protein translation due to loss of RBPs or free mRNA could also 
negatively impact the cell (Wolozin, 2012). In diseases where tau inclusions exist, such 
as frontotemporal dementia with parkinsonism-17 (FTDP-17) and Alzheimer’s disease 
(AD), it has been shown tau co-localizes with SGs, potentially causing increased tau 
accumulation in the cell (Vanderweyde et al. 2013). Evidence also suggests that in 
addition to SGs stimulating development of phosphorylated tau inclusions (Vanderweyde 
et al. 2012), tau appears to reciprocally stimulate SG formation (Vanderweyde et al. 
2013). Interestingly, in many cases of neurodegenerative tauopathies, SG inclusions 
actually display greater density than NFTs, suggesting that total pathological inclusions 
in a neuron are much greater than regions simply containing tau protein (Vanderweyde et 
al. 2013). It should be noted that the specific RBPs present in an SG determine the 
pathological properties of the SG (Vanderweyde et al. 2012).  
Review of RNA-Binding Proteins 
Overall, RBPs have two conserved motifs providing their function: a component 
that allows them to bind to RNA and a component that contains a large proportion of 
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glycine amino acids, allowing for interaction with other proteins due to strong 
hydrophobic interactions (Wolozin, 2014; Vanderweyde et al. 2013). Their RNA-binding 
component allows RBPs to regulate the translation of mRNAs by providing stability to 
the transcript, specifically by binding to an untranslated or coding region (Liu-Yesucevitz 
et al. 2011). In the non-stress state, RBPs exist both in the nucleus, where their function is 
for mRNA maturation including helicase function, splicing, nuclear export, and RNA 
polymerase elongation; however, in a stressed-state, RBPs leave the nucleus for the 
cytoplasm where their main function is to mainly inhibit the translation process by 
binding to free mRNA, in turn causing the formation of SGs (Vanderweyde et al. 2013).  
It is important to realize that RBPs function as critical pathways in local RNA 
translation and mutations in these proteins often results in a specific neurologic disease 
(Liu-Yesucevitz et al. 2011). Diseases linked to mutations in RBPs include amyotrophic 
lateral sclerosis (ALS), frontotemporal dementia, and spinal muscular atrophy, and play a 
role in other diseases such as AD and Creutzfeld-Jacob disease (Vanderweyde et al. 
2013). Mutations resulting in disease generally either influence granule aggregation or 
mRNA processing (Liu-Yesucevitz et al. 2011). For example, TDP-43 normally assists 
delivery of mRNA transcripts via microtubule transport to different regions of the 
neuron; specific mutations for TDP-43, however, have been linked to specific 
neurodegenerative diseases, such as ALS (Alami et al. 2014).  
One example on an RBP implicated in neurodegenerative tauopathies is TIA-1. 
This RBP normally functions by targeting C-rich and U-rich mRNA transcripts and 
represses translation of these transcripts (Vanderweyde et al. 2013). Examples of 
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transcripts impacted include TNF- and COX-2 (Vanderweyde et al. 2013). Based on the 
inflammatory function of these proteins, suppression of TIA-1 results in auto-
inflammatory symptoms, such as mild arthritis (Phillips et al. 2004). When mutated to not 
have its RNA-binding domains, TIA-1 inhibits SG formation (Kedersha et al. 1999). In 
tauopathies, TIA-1 has been shown to bind to tau protein and that if TIA-1 is 
overexpressed, this may cause increased formation of hyperphosporylated tau inclusions 
(Vanderweyde et al. 2012). 
Therapeutic Options for Tauopathies 
Currently, most treatment options for neurodegenerative ailments such as AD are 
only capable of managing symptoms, and generally only for a short timeframe (Meier et 
al. 2016). Because atrophy in the brain is a major symptom, neuronal loss is inevitable in 
most diseases (deToldeo-Morrell et al. 2007). For this reason, one of the main therapeutic 
options is providing neurotransmitters to patients since individuals lose the ability to 
generate neurotransmitters with neuronal loss (Selkoe, 2001). One of the most useful 
supplements for treatment of conditions like AD being acetylcholine (Selkoe, 2001). 
As was shown earlier with AD, neuronal atrophy can be quite significant before 
clinical symptoms become apparent (deToldeo-Morrell et al. 2007). For this reason, one 
method crucial for treating most tauopathies would be early detection through 
biomarkers. Glodzik et al. 2011 noted that biomarkers in cerebral spinal fluid (CSF) may 
be able to perform this task, noting that elevated hyperphosphorylated tau was found to 
be linked to both a decrease in declarative memory and neuronal loss of the medial 
temporal lobe; it should be noted that hyperphosphorylated tau has been shown to have a 
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positive correlation with age, especially in older populations (Jaworski, et al. 2009). 
Additionally, it has been noted that some neurodegenerative diseases such as AD usually 
begin with MCI. Being able to predict if MCI will progress to AD would be beneficial as 
treatment options could begin earlier, potentially delaying progression of MCI to AD 
(Ewers et al. 2012). Testing for potential biomarkers that would predict this disease 
progression, Ewers et al. 2012 noted that the best model was a high tau/Aβ ratio paired 
with clinical testing showing decreased performance in immediate and delayed recall.  
Finally, in tauopathies, tau can become mutated, preventing them from binding to and 
stabilizing microtubules. If drugs can be generated that can help stabilize microtubule 
polymerization to allow for little disruption in axonal transport, this could help alleviate 
many of the morphological changes seen in neurons due to dendrites not being able to 
receive necessary resources (Roy et al. 2005). Finally, drugs that deacetylate tau lysine 
residues could be therapeutic as it has been shown that tau acetylation has a role in 
pathological tau transformation (Cook et al. 2014). 
Purpose of Study 
 The purpose of the present study is to analyze the morphological impact 
that tau can have on dendritic processes for neurons. The entorhinal cortex will be the 
region studied since important diseases such as AD are known to cause symptoms of 
neuron atrophy in the early course of the disease. Additionally, fan and stellate cells will 
be compared to identify if they respond differently in tauopathies. The present study 
employed the P301S mouse model, a genotype containing a tau gene mutation resulting 
in FTDP-17 at an advanced rate. Previous studies have shown this genotype to have a 
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decrease in synapse density in the hippocampus at three months, tau plaque formation at 
six months, and finally neuronal atrophy in the hippocampus and entorhinal cortex by 
twelve months (Yoshiyama et al. 2007). The P301S model overexpresses mutant tau by 
roughly five times compared to endogenous tau expression (DeVos et al. 2017), useful 
for analyzing the effect that overexpression of tau can have on neuron function and 
morphology. In contrast to WT tau, this mutation was found to decrease binding capacity 
and binding affinity for microtubules, a crucial pathogenic property of tauopathies (Hong 
et al. 1998). 
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METHODS  
Mice Used in the Study 
The P301S mouse model of tauopathy with TIA1 knockdown was used in this 
study. Brain slices were prepared from the following two genotypes of mice: P301S tau (-
/-), TIA1 (+/+) (namely wildtype or WT) and P301S tau (+/-), TIA1 (+/+); the specific 
ages and genders for each of the six mice studied is in Table 1. Mice were provided and 
cared for in the Laboratory Animal Science Center of the Boston University Medical 
Center. All animals were managed under guidelines from the American Association for 
the Accreditation of Laboratory Animal Care. Additionally, all procedures were done 
under strict animal care guidelines from the NIH Guide for the Care and Use of 
Laboratory Animals and the U.S. Public Health Service Policy on Humane Care and Use 
of Laboratory Animals. 
 
Table 1: Genotype, gender, and age of each mouse utilized in study 
Genotype Gender Age 
P301S tau (-/-), TIA1(+/+) Female 6.3 months 
P301S tau (-/-), TIA1(+/+) Male 6.5 months 
P301S tau (-/-), TIA1(+/+) Male 6.5 months 
P301S tau (-/-), TIA1(+/+) Male 6.6 months 
P301S tau (+/-), TIA1 (+/+) Female 6.5 months 
P301S tau (+/-), TIA1 (+/+) Male 6.5 months 
 
Perfusion/Preparation of Brain Slices 
Mice were first anesthetized with isofluorine and then euthanized via 
decapitation, allowing for removal of the brain. The brain was placed in ice-cold Ringer’s 
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Solution (124 mM NaCl, 1.0 mM KCl, 2.0 mM KH2PO4, 1.3mM MgCl2, 2.5 mM CaCl2, 
10 mM Glucose) and then sectioned into 300 µm slices using a vibratome after mounting 
on an agar slab. The specific slices incorporated for this study included neurons from the 
medial entorhinal and lateral entorhinal cortices, with the majority of neurons coming 
from the lateral entorhinal cortex. The slices were then placed in room temperature 
oxygenated Ringer’s solution and left for one hour to equilibrate.  
Electrophysiological recordings (a discussion of which is beyond the scope of this 
thesis) were conducted on the neurons visually identified using a Nikon E600 infrared-
differential interference contrast (IR-DIC) microscope (Micro Video Instruments, Avon, 
MA). This process utilized a submersion recording chamber (Harvard Apparatus, 
Holliston, MA) where tissue slices were stabilized and continuously supplied with a flow 
of oxygenated Ringer’s solution. Neurons were injected with 0.5% biocytin during the 
recordings.   
The neurons filled with biocytin during electrophysiological recordings were 
fixed in 4% paraformaldehyde and incubated overnight. Following this, tissue slices were 
rinsed in 0.1 M phosphate buffered saline (PBS) buffer solution three times for ten 
minutes each and then washed in a buffer containing 1% Triton X-100 for 2 hours at 
room temperature to increase permeability of tissue slices. Slices were then labeled using 
streptavidin fluorescent conjugates—specifically Alexa-Streptavidin Fluor 488 (1:500, 
Life Technologies)—for two days at 4C. Following this, slices were again rinsed three 
times in 0.1M PBS buffer solution, and then stored in PBS-Azide, and eventually 
transferred into an anti-freeze solution to complete the process. 
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Confocal Imaging 
Neurons were scanned in 3D with a high-resolution Zeiss 510 Confocal Laser 
Scanning Microscope (CLSM), with a 20x 0.5 NA water-immersion objective lens. 
During imaging, a 488 nm laser powered at approximately 30% (29.5-30.4%) was used to 
excite the fluorophores located within the neuron, with the detection range of the 
excitation/emission curve wavelength ranging from 493 nm-560 nm. For the image 
collected, a resolution of 2048 x 2048 pixels was used; this, along with setting the z-stack 
size at 0.5 µm, resulted in an overall resolution of a 0.26869 x 0.26869 x 0.5 µm voxel 
size to produce the image for analysis of the morphological characteristics of dendrite 
and soma. During all image processing, the microscope incorporated a scanning speed of 
400Hz and a detection pinhole set at 1 Airy Unit. 
While imaging individual neurons, the X-, Y-, and Z- planes were set to ensure 
the entirety of the neuron’s dendrites would be incorporated into the image. After 
determining these parameters, the amount of saturation was adjusted roughly every 10 
µm in the Z-plane to ensure that dendrites would be adequately imaged; this process 
consisted of attempting to saturate the image to the extent that one pixel of a dendrite 
would have a degree of oversaturation at each Z-stack. Additionally, the offset of the 
image was adjusted every 10 µm to ensure that background was minimized; this process 
consisted of ensuring that all true black spaces were recognized while also ensuring that 
no artificial black spaces disrupted dendritic integrity. 
The acquired confocal images were then deconvolved with AutoQuant software 
(Media Cybernetics, Bethesda, MD) to reverse optical distortion in the z plane, allowing 
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for clearer images of the neuronal dendrites; an example of the restoration effect is shown 
in Figure 4. This was necessary to adjust for the scattering of light that could contribute 
to increased background noise. Following this, the files were converted from 16-bit to 8-
bit .tif files allowing for dendrite and soma reconstruction using NeuroLucida 360 (MBF, 
Vermont). 
 
 
Figure 4. Example of a confocal image before (left) and after (right) deconvolution 
utilizing AutoQuant software. The neuron used in this example is Feb2IR1d. Scale bar: 
100 µm. 
 
Neuron Reconstruction 
Image stacks were loaded into NeuroLucida 360 for reconstruction of the neuron 
cell bodies and dendrites. Dendrites were reconstructed using a semi-automated user-
guided tracing mechanism, while the soma was reconstructed via an automatic 
mechanism, determining the soma’s volume. Upon completion, the files were loaded into 
the 64-bit version of NeuroLucida where manual inspection took place to ensure that all 
dendrites were reconstructed accurately as well as to ensure that no dendrites were 
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missed in the reconstruction process. Additionally, information that would be 
incorporated into analysis was confirmed, such as ensuring correct nodal points where 
dendrites branch were accurate. An example of a neuron after complete reconstruction 
and editing can be seen in Figure 5. 
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Figure 5. Representation of a neuron before and after reconstruction and editing 
using NeuroLucida. The image on the left is of an unaltered 8-bit image file in 
NeuroLucida 360 program before any neuron reconstruction has commenced. The image 
on the right shows what the neuron looks like after it has been reconstructed and edited. 
The neuron used in this example is Feb2IR1d. Scale bar: 100 µm. 
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Neuron Analysis 
Neurons were analyzed using NeuroLucida Explorer. Morphological features of 
analyzing the branched structure of the neuron including, for example, description of 
nodal positions, straight line distance of individual dendrites, and dendrite tortuosity. 
Additionally, Sholl analysis was conducted to provide an overview of dendrite branch 
length, dendritic surface area, and number of dendritic intersections in relation to a set of 
concentric spheres centered at the cell body. Finally, a convex hull analysis, an operation 
used to map out the volume or surface area of an object by creating a polygon that 
encompassing all points inside of constructed shape, was employed, useful for acting as a 
model for understanding the amount of overall physical space taken up by the neuronal 
dendrites. 
Statistical Analyses 
Microsoft Excel was used for organizing data both for statistical analysis and 
graphical representation. Homoscedastic, non-paired t-tests were used when assessing for 
statistical significance which was defined for a p-value being less than 0.05. 
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RESULTS 
Morphological data was obtained from 29 neurons in the lateral entorhinal cortex 
of the mouse. Visual inspection was used to determine if a neuron could be classified as a 
fan cell, stellate cell, or some other type of neuron based on characteristic features of the 
neurons reported in the literature (Alonso and Kirk, 1993; Canto et al. 2008; Marcantoni 
et al., 2014; Tahvildari and Alonso, 2005). Of the total number of cells recorded, 13 came 
from the P301S tau (+/-), TIA1 (+/+) genotype (which was designated “tau”) and 16 
came from the P301S tau (-/-), TIA1 (+/+) genotype (which was designated “WT”). Of 
the cells recorded in the tau mice, five were fan cells, five were stellate cells, and three 
were cells of some other classification (multipolar, horizontal tripolar, and pyramidal). Of 
the cells recorded in the WT mice, five were fan cells, ten were stellate cells, and one cell 
was of some other classification (oblique pyramidal). Based on the number of cells 
available, morphological analysis and comparisons were made for neurons based on their 
genotype (tau or WT) as well if their neuron classification was that was considered to be 
either a fan cell or stellate cell. 
Visual Morphological Analysis of Neurons 
 The reconstructed fan cells had a typical appearance in that their dendrites did not 
diverge from the soma in a uniform, multidirectional pattern; instead, dendrites tended to 
branch in a horizontal manner as well as orthogonal in one direction to this plane. An 
example of an ideal representation of a fan cell is shown for Feb2IR1d in Figure 6 where 
these dendrites are heading towards the pia. This was not always the case as sometimes a 
few dendrites would branch opposite in the direction of the pia (e.g. Feb4IR1b, 
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Mar9IR2h; Figure 6), but upon closer inspection, it was noted that dendrites heading 
towards the pia outnumbered dendrites heading in the opposite direction, which is also 
noted in the literature that fan cells may possess a few dendrites which branch in this 
pattern (Tahvildari and Alonso, 2005). Stellate cells, on the other hand, branch in a more 
uniform and equidistant pattern from the soma. These neuron’s dendritic branching 
characteristics can be appreciated in Figure 6. 
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Figure 6. Three-dimensional projection of tau (P301S tau (+/-), TIA1 (+/+)) and WT 
(P301S tau (-/-), TIA1 (+/+)) neurons used in this study. Neurons are grouped by 
neuron classification. Their Cell ID’s are provided under the image. Images were 
assembled using Illustrator from data collected via NeuroLucida Explorer. 
Tau- Stellate Cells 
Tau- Other Cells 
Feb2IR1d Mar9IR2h Mar9IR1c Feb2IR2a Feb2IR1e 
Mar9IR2d Mar9IR2c Feb5IR2h Feb5IR2f Feb5IR2b 
Mar9IR2i Mar9IR2e Feb2IR2e 
WT-Fan Cells 
Feb8IR2g Feb8IR2f Feb4IR1b Feb3IR2g 
WT- Stellate Cells 
Feb3IR2c Feb3IR2b Feb3IR1c Feb3IR1b Jan26IR3f 
Feb3IR2l Feb3IR2k Feb3IR2f Feb3IR2e Feb3IR2d 
WT- Other Cells 
Feb8IR2d 
Tau- Fan Cells 
Jan26IR2b 
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Primary Dendrite Quantity Analysis 
One measure of neural complexity is the number of individual primary dendrites 
branching off of the cell body. During neuronal reconstruction, primary dendrite counts 
were made. When sub-classifying the tau and WT neurons into categorical definitions of 
fan versus stellate cells based on morphological analysis of the confocal images taken, it 
was found that WT stellate cells on average had significantly more primary dendrites 
than tau stellate cells (8.4 ± 1.8 (n=10) vs 6.4 ± 1.1 (n=5), p=0.046) (Fig 7B). 
Interestingly, this trend differed in fan cells where tau fan cells were found to have a 
higher number of primary dendrites compared to WT fan cells (7.0 ± 1.4 (n=5) vs 5.2 ± 
1.1 (n=5), p=0.055) (Fig 7B). As a whole, stellate cells on average were found to have a 
significantly higher count in primary dendrites compared to fan cells (7.7 ± 1.9 (n=15) vs 
6.1 ± 1.5 (n=10), p=0.031) (Fig 7A). This trend continued to a greater extent when solely 
analyzing WT neurons where the average primary dendrite count difference jumped to 
8.4 ± 1.8 (n=10) vs 5.2 ± 1.1 (n=5), p=0.004 (Fig 7B). On the other hand, this trend of 
stellate cells having a greater number of primary dendrites was lost entirely when 
analyzing solely tau cells as tau fan cells were actually not found to have a difference in 
number of primary dendrites compared to tau stellate cells (7.0 ± 1.4 (n=5) vs 6.4 ± 1.1 
(n=5), p=0.481) (Fig 7B). 
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Figure 7. Box and whisker plots of the average primary dendrite number based on 
neuron classification and/or genotype. A) The average primary dendrite quantity for 
tau, WT, fan, or stellate neurons. B) The average primary dendrite quantity for when 
differentiating by neuron classification and genotype. *p<0.05; **p<0.005. 
 
Dendritic Node/Ending Analysis 
To analyze the extent of dendritic branching, the quantity of nodes (representing 
the points at which the dendrite branches) and endings (representing the total end points 
of all dendrites) were quantified. Theoretically, the number of nodes and endings should 
be related, in the sense that endings should equal the sum of primary dendrites and nodes 
per neuron (E = N + D). Overall, node and ending quantity followed the same pattern 
among different neuron classifications as was found when analyzing primary dendrite 
quantity. That said, there were fewer statistically significant relationships, with no strong 
differentiation when comparing overall tau to WT neurons and when comparing fan to 
stellate cells (Fig 8 A,C). Two significant findings were that WT stellate cells possessed a 
higher number of nodes and endings than tau stellate cells (nodes: 37.9 ± 8.5 (n=10) vs 
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26.4 ± 7.5 (n=5), p=0.024; endings: 45.9 ± 9.5 (n=10) vs 33.0 ± 7.4 (n=5), p=0.020) (Fig 
8 B, D) and WT stellate cells having more nodes and endings than WT fan cells (nodes: 
37.9 ± 8.5 (n=10) vs 24.2 ± 11.9 (n=5), p=0.023; nodes: 45.9 ± 9.5 (n=10) vs 29.4 ± 12.0 
(n=5), p=0.012) (Fig 8 B,D). Tau fan cells were not found to have more nodes and 
endings than tau stellate cells, despite tau fan cells possessing more primary dendrites 
(Fig 8 B, D). 
 
Figure 8. Box and whisker plots of the node and ending count based on neuron 
classification and/or genotype. A) The average node count for tau, WT, fan, or stellate 
neurons. B) The average node count for when differentiating by neuron classification and 
genotype. C) The average ending count for tau, WT, fan, or stellate neurons. D) The 
average ending count for when differentiating by neuron classification and genotype. 
*p<0.05. 
 40 
Dendritic Length Analysis 
Total dendritic length between Tau and WT or fan and stellate cell did not differ 
(Fig 9A). Additionally, mean dendritic length also did not show a difference between Tau 
and WT neurons (Fig 9C); that said, fan and stellate cells overall did show a trend in 
differing with fan cells on average having longer dendrites when compared to stellate 
cells (997.3 ± 396.5 m (n=10) vs 769.5 ± 269.8 m (n=15), p=0.100) (Fig 9A). Taken 
together with the earlier finding of stellate cells as a whole having significantly more 
primary dendrites than fan cells, this data reveals that, with regard to the morphological 
features of the two neuron classifications, stellate cells possess on average more dendritic 
branches but have a shorter overall length, whereas fan cells possess fewer branching 
dendrites from the soma, but each of these dendrites has a longer average length. 
Functionally, this morphological pattern makes sense; the asymmetrical design of the fan 
cell where all dendrites branch apically towards the pia with no basal extensions would 
imply a smaller number of primary dendrites, and since neurons rely on dendrites for 
enhanced surface area for signal reception from neighboring neurons, assuming identical 
need for signaling, it makes sense that both neuron classifications would have similar 
overall surface area. 
When sub-typing the WT and tau cells into their fan and stellate cell subclasses, a 
similar trend to what was observed for number of primary dendrites and number of nodes 
and endings was found for total dendritic length: on average, tau fan cells showed a trend 
of having a greater average total dendritic length when compared to WT fan cells (7047.6 
± 1540.6 m (n=5) vs 4753.4 ± 2203.1 m (n=5), p=0.093), and WT stellate cells were 
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found to have a significantly greater average total dendritic length compared to tau 
stellate cells (6354.7 ± 1642.0 m (n=10) vs 4541.0 ± 1242.8 m (n=5), p=0.050) (Fig 
9B). It is also of interest to note that once again, the WT mouse model failed to differ in 
comparison when comparing the overall dendritic length of stellate cells to fan cells 
(6354.7 ± 1642.0 m (n=10) vs 4753.4 ± 2203.1 m (n=5) , p=0.135); on the other hand, 
in the tau mouse model, fan cells had a significantly greater total dendritic length 
compared to stellate cells (7047.6 ± 1540.6 m (n=5) vs 4541.0 ± 1242.8 m (n=5), 
p=0.022) (Fig 9B). 
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Figure 9. Box and whisker plots of the total dendritic length and mean dendritic 
length on neuron classification and/or genotype. A) The average total dendritic length 
for tau, WT, fan, or stellate neurons. B) The average total dendritic length for when 
differentiating by neuron classification and genotype. C) The average mean dendritic 
length for tau, WT, fan, or stellate neurons. D) The average mean dendritic length for 
when differentiating by neuron classification and genotype. *p<0.05. 
 
Overview of Sholl Analyses 
Sholl analysis is a quantitative method to characterize structural features of 
dendrites –their topology- by creating a system of concentric circles of increasing radius 
stemming from the cell body. By doing this, an overall assessment of dendritic arbor 
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complexity can be modeled. For this analysis, intersections, dendritic length, and surface 
area was conducted utilizing a radius of 10 m for concentric rings. 
Sholl Analysis: Intersections 
Intersections are defined as dendrites crossing a radial concentric ring centered at 
the cell body of the neuron and extending in a somatofugal manner. This analysis can 
provide valuable information in terms of better understanding the complexity of dendritic 
branching: for example, if two neuron types were found to have roughly equal number of 
primary dendrites but one neuron type had a greater number of intersections close to the 
soma, that data could be suggestive that this neuron type may have a greater degree of 
dendritic branching closer to the soma.  
When comparing WT and tau neurons, WT was found to have a significantly 
greater number of intersections between 20-50 m from the soma, but after this point, 
intersections once again became roughly equal (Fig. 10A). By distinguishing between 
stellate cell and fan cell when comparing the WT and tau neurons, further trends were 
noted. Tau fan cells were shown to consistently have a higher number of intersections 
throughout the entire Sholl analysis when compared to WT fan cells, with large regions 
where this difference was statistically significant between 110-230 m (Fig. 10C). 
Contrastingly, when analyzing only stellate cells, neurons from the WT genotype were 
shown to predominantly have more interactions throughout the Sholl analysis, with points 
of significant differences in the range of 20-50 m from the somal center (Fig. 10 D). 
When analyzing by neuron type, it was found that although stellate cells had a 
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significantly greater number of intersections between 20-50 m from the soma compared 
to fan cells; this trend then reversed at a radius of 140-200 m away from the soma with 
fan cells then having significantly higher number of intersections (Fig 10 B). This trend 
makes some sense since stellate cells were earlier shown to have a higher number of 
primary dendrites than fan cells (7.7 ± 1.9 (n=15) vs 6.1 ± 1.5 (n=10), p=0.031) which 
would aid that neuron type in possessing more primary dendrites to aid in branching to 
potentially inflate the amount of intersections near the soma. By 140 m away from the 
cell body, however, the trend had reversed with fan cells now having a significantly 
higher number of intersections compared to stellate cells, suggestive that the degree of 
branching had increased for fan cells prior to this point between 60-130 m in 
comparison to stellate cells. When analyzing solely WT neurons, stellate cells were found 
to once again possess this trait of having a significantly greater number of intersections 
close to the soma in comparison to fan cells (20-60 m), though there was no significant 
difference in intersections between the two neuron types after this point (Fig. 10 F). 
Conversely, when analyzing tau cells, there was no early deviation in number of 
intersections between fan and stellate cells; that said, at roughly 110 m away from the 
soma fan cells were shown to have a significantly greater number of intersections 
compared to stellate cells until roughly 220 m away from the soma, with many 
differences between the two groups having a statistical significance where p<0.005 (Fig 
10 E). 
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Figure 10. Intersection Sholl analyses comparison based on neuron classification 
and/or genotype. A) Sholl analysis of the total number of intersections in 10m 
increments comparing tau and WT neurons. B-F were the same as in A except compared 
different neuron classifications and/or lineages. B) Comparison of fan and stellate cells. 
C) Comparison of fan cells by genotype (tau or WT). D) Comparison of stellate cells by 
genotype (tau or WT). E) Comparison of tau neurons by neuron classification (fan or 
stellate). F) Comparison of WT neurons by neuron classification (fan or stellate). 
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Sholl Analysis: Dendritic Length 
Dendritic length in the Sholl context is defined as the length of dendrite located 
between each concentric ring. Overall, the results found when comparing neuron type and 
neuron genotype match closely to what was found when analyzing number of 
intersections; conceptually, this makes sense as a large factor for determining the number 
of intersections as well as overall length of dendrites would be the degree of branching. 
That said, any relative increase in dendritic length compared to intersection amount might 
suggest dendrites that curve at a tangential way to the concentric rings as opposed to 
dendrites that simply extend radially from the cell body. 
When comparing cells by genotype, similar to what was found when analyzing 
for intersection amount, WT cells were found to have a greater overall dendritic length 
compared to tau cells close to the soma, but the difference was not as extreme when 
compared to analyzing number of intersections, with the difference only reaching 
statistical significance at one marker—20 m from the soma (Fig. 11 A). When isolating 
by neuron type and then comparing neuron genotype, similar findings to what was found 
for intersection amount was again observed. Tau fan cells were once again observed to 
have a greater overall dendritic length compared to WT fan cells for the majority of the 
Sholl analysis, but these differences were not as extreme as when comparing the findings 
for intersection amount (Fig. 11 C). 
When comparing neuron type, dendritic length was found to be greater in stellate 
cells compared to fan cells in regions closer to the soma (statistically significant between 
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20-60 m), while the reverse trend of fan cells possessing greater dendritic length was 
found in regions further from the soma (statistically significant between 170-210 m) 
(Fig. 11 B). Looking only at WT neurons, the trend of stellate cells possessing longer 
average dendritic length close to the soma continued (statistically significant between 20-
50 m), however after this point total dendritic length remained roughly similar for both 
stellate and fan cells (Fig. 11 F). When analyzing only tau neurons, there was no 
difference in dendritic length close to the soma. As the radius moved further from the 
soma, however, fan cells began to show a significantly larger dendritic length compared 
to stellate cells (statistically significant between 120-220 m) (Fig. 11 E).  
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Figure 11. Dendritic length Sholl analyses comparison based on neuron 
classification and/or genotype. A) Sholl analysis of the total dendritic length in 10m 
increments comparing tau and WT neurons. B-F were the same as in A except compared 
different neuron classifications and/or lineages. B) Comparison of fan and stellate cells. 
C) Comparison of fan cells by genotype (tau or WT). D) Comparison of stellate cells by 
genotype (tau or WT). E) Comparison of tau neurons by neuron classification (fan or 
stellate). F) Comparison of WT neurons by neuron classification (fan or stellate). 
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Sholl Analysis: Surface Area 
As one of the main roles of dendrites is the ability to integrate electrochemical 
signals from other neurons, dendrite arbors with increased surface area generally have a 
stronger capability of performing this function due to increased access for other neuronal 
processes to connect. In this regard, surface area is crucial metric for determining a 
neuron’s interconnectivity to its surrounding environment. 
Overall, WT and tau neuron genotypes showed no differences in average surface 
area of dendrites throughout the Sholl analysis (Fig. 12 A). When also distinguishing by 
neuron type, however, differences were noted. For example, when comparing WT and tau 
fan cells, it was noted that tau fan cells had significantly greater surface area in the 
vicinity of 160-220 m (Fig. 12 C). On the other hand, while comparing WT and tau 
stellate cells, no differences in surface area were noted (Fig. 12 D). 
When analyzing by neuron type, fan cells were found to have significantly greater 
surface area between 140-220 m away from the soma (Fig. 12 B). This pattern was 
intensified when looking only at tau neurons, where fan cells were found to have 
statistically significant greater surface at a range of 100-220 m away from the soma 
(Fig. 12 E). WT neurons, on the other hand, did not show as strong a trend for one type of 
neuron having greater surface area, with data only suggesting that stellate cells have a 
greater average surface area relatively close distance to the soma: 30-40 m away (Fig. 
12 F).  
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Figure 12. Dendritic surface area Sholl analyses comparison based on neuron 
classification and/or genotype. A) Sholl analysis of the total surface area in 10m 
increments comparing tau and WT neurons. B-F were the same as in A except compared 
different neuron classifications and/or lineages. B) Comparison of fan and stellate cells. 
C) Comparison of fan cells by genotype (tau or WT). D) Comparison of stellate cells by 
genotype (tau or WT). E) Comparison of tau neurons by neuron classification (fan or 
stellate). F) Comparison of WT neurons by neuron classification (fan or stellate). 
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Overall Sholl Radius 
Lastly, neurons were analyzed to determine average Sholl radius, signifying the 
greatest extent a dendrite extended from the cell body of the neuron. Interestingly, tau fan 
cells were found to have the largest Sholl radius of 328.0 ± 22.8 m (n=5). This was 
significantly greater than both tau stellate cells (266.0 ± 54.6 m (n=5), p=0.047) as well 
as WT fan cells (272.0 ± 27.7 m (n=5), p=0.009) (Fig. 13).  
 
 
 
Figure 13. Box and whisker plots of the overall Sholl radius based on neuron 
classification and genotype. *p<0.05. 
 
3D Convex Hull Analysis 
In its simplest understanding, convex hull is an operation utilizing the smallest set 
of points which when taken together, create a polygon that encompass all other points 
inside of the shape- in other words it represents the volume of neuropil occupied by the 
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entirety of the neuron. For the analysis of neurons, the distal most points of the neuron’s 
dendrites act as the points used to create a convex polygon. The significance of this 
analysis is this shape acts as a representation of the dendritic field for the neuron, 
allowing for a model representation of the volume and surface area of the neuron. 
For both volume and surface area analysis after creating the convex hull, only the 
comparison of tau fan cells to WT fan cells were found to be statistically significant, with 
tau fan cells being larger in both categories (volume: p=0.020; surface area: p=0.028) 
(Fig. 14 A,B). Interestingly, the results in general correspond to the findings from the 
different categories analyzed during Sholl analysis. 
 
 
 
Figure 14. Box and whisker plots of the Convex Hull 3D analysis based on neuron 
classification and genotype. A) Convex Hull 3D volume analysis based on neuron 
classification and genotype. B) Convex Hull 3D surface area analysis based on neuron 
classification and genotype. *p<0.05. 
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DISCUSSION 
The key goal of this study was to determine the effects that tau has on the 
morphological properties of dendrites of fan and stellate cells in the entorhinal cortex. To 
do this, the transgenic P301S mouse model was employed, was then compared to a non-
transgenic WT mouse genotype. Additionally, cells in the entorhinal cortex were 
analyzed due to the understanding that this region of the brain being one of the earliest to 
be affected in the neurodegenerative disease AD, with atrophy noted even in the 
precursor ailment of MCI (deToldeo-Morrell et al. 2007). Two types of neurons in 
particular were analyzed to determine differences in response to tauopathies: fan cells and 
stellate cells.  
Interestingly, of the two neuron types studied in depth, very different 
morphological responses to the presence of mutant tau were observed. Across multiple 
parameters for measuring dendrites, a common theme found was dendritic regression in 
stellate cells in tau mutant mice relative to WT. On the other hand, when examining fan 
cells, it was noted that dendrite complexity actually increased in tau mice in comparison 
to the WT genotype in some instances. Overall, tau stellate cells were found to have far 
fewer primary dendrites in comparison to the non-transgenic mouse model (p=0.004) 
(Figure 1 B). When analyzing dendrite complexity, again stellate cells affected by the 
tauopathy were shown to have fewer nodes and endings when compared to the WT mice 
(Figure 2 B,D). Fan cells that were exposed to tau, on the other hand, did not demonstrate 
a decrease in primary dendrites or in complexity. Total dendritic length was another 
parameter examined, and once again, tau stellate cells exhibited a significant decrease in 
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length when compare to WT stellate cells (Figure 3 B). It is also interesting to note that 
tau stellate cells did not differ in mean dendritic length compared to WT stellate cells 
(Figure 3 D). Taken together with the fact that tau stellate cells had significantly less 
overall dendritic length compared to WT stellate cells suggests that the atrophy which 
stellate cells undergo is a reduction in overall number of dendrites rather than shortening 
of dendrites. The Sholl analysis conducted shows that stellates are negatively affected by 
tauopathies in the sense that their complexity and dendritic length decreased within 
dendrites closest to the soma. Conversely, when fan cells were impacted by transgenic 
tau, their complexity, dendritic length, and surface area actually increased further out 
from the soma, roughly 130-240 m from the center. Fan cells were shown to 
significantly increase in both overall Sholl radius (Figure 7) and increase in three-
dimension volume and surface area based on a convex hull analysis when comparing the 
transgenic tau mouse model to the WT genotype (Figure 8 A,B). 
Although many studies have shown that neurodegenerative diseases can have 
dystrophic effects on neuronal morphology, less is known about the effects tau can have 
on neuronal structure (Luebke et al. 2010). Previous studies have shown tauopathies 
resulting from mutant tau negatively impact dendritic arbors by inducing atrophy, causing 
a decrease in both dendritic length and complexity (Rocher et al. 2010). Some studies 
have suggested that cells may respond to increased tau by having dendritic proliferation 
rather than degeneration. Crimins et al. 2012 noted just this when studying frontal 
cortical slices in layer III for pyramidal neurons from rTg4510 tau mutant mice. At eight 
months, neurons were labeled as either “intact”—meaning their dendritic morphology did 
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not vary substantially from the WT genotype, or “atrophic”—meaning that the dendritic 
morphology was experiencing significant atrophy. Like the fan cells in this study, 
“intact” transgenic cells in the Crimins et al. 2012 study showed an increase in dendritic 
length and complexity near the apical arbor, very close to the soma. This somewhat 
differs in the Sholl analysis conducted for fan cells in this study which showed that 
compared to WT fan cells, dendritic complexity (based on count of intersections) and 
dendritic length did not increase until after roughly 100 m from the soma. Transgenic 
cells that were considered “atrophic” in the Crimins et al. 2012 study exhibited 
significant reduction in total dendritic length, similar to how tau stellate cells in this study 
recorded a loss in dendritic length compared to WT stellate cells. The Crimins et al. 2012 
study showed that this group of neurons showed reduction in dendritic length throughout 
the dendritic arbor; stellate cells in this study, however, showed reduction in dendritic 
length and complexity only in regions closest to the soma for roughly the first 100 m. 
Dickstein et al. 2010 also analyzed pyramidal cells of layer III, this time in the prefrontal 
cortex. Key findings regarding alterations in dendritic morphology of neurons exposed to 
tau showed that up to 6 months the only notable difference between htau and WT mice 
was that htau mice had a shorter basal dendritic length compared to WT mice. At 12 
months, despite having a strong presence of hyperphosphorylated tau found in dendrites, 
there was no noteworthy difference in dendritic length when comparing tau and WT 
mice. A Sholl analysis conducted in Dickstein et al. 2010 revealed increase in both 
dendritic length and complexity between 30-120 m from the soma. In this study, tau fan 
cells also showed an increase in dendritic length and complexity when a Sholl analysis 
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was conducted, but tau fan cells in this study only showed increased dendritic length and 
complexity over WT fan cells further from the soma, at roughly 120-240 m. That said, it 
should be noted that Dickstein et al. 2010 utilized non-mutated human tau rather than 
mutated tau in the mice genotype expressing tau. This is noteworthy as htau may not have 
the same extent of deleterious effects as found in mutated tau, such as in the P301S 
mutation which has been found to have a decrease binding affinity for microtubules 
(Hong et al. 1998). 
One important unanswered question in this study is why tau seemed to have a 
significant but opposite impact on fan and stellate cell dendritic morphology. When 
analyzing the morphology of fan and stellate cells, one key distinction is the presence of 
spines. One crucial trait found in stellate cells is their strong propensity for having spines 
on their dendrites, while fan cell dendrites, contrastingly, are only sparsely populated 
with spines (Tahvildari and Alonso, 2005). This may be significant as it has been shown 
that one of the first pathologic loci for tau protein to aggregate once becoming 
hyperphosphorylated is in spines (Hoover et al. 2010). Once here, damage to the neuron 
can occur by hyperphosphorylated tau impairing glutamate receptor trafficking and 
synaptic anchoring, suppressing important synaptic function for the neuron (Hoover et al. 
2010). If one cell has a large amount of spines, this may create a fruitful environment for 
phosphorylated tau to accumulate to a larger degree compared to a neuron which has a 
lesser spine density. Too great of a spine density may allow tau accumulation to 
overwhelm the cell through pathologic interactions such as inhibiting axonal transport, 
potentially creating a stress signal too great for the neuron to respond, thus resulting in a 
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response of dendritic atrophy. On the other hand, if the stress caused on the neuron from 
tau accumulation is not as great, the neuron may attempt to alleviate the stressor in a 
different manner. For example, Crimins et al. 2012 noted that one plausible explanation 
for the oblique sprouting of dendrites in some neurons impacted by tauopathy could be a 
result of deafferentation. For example, if a neuron were to lose signaling from one section 
of a dendrite due to pathologic complications from tau, neural plasticity may allow it to 
sprout additional dendrites in order to compensate for the initial loss of dendritic 
signaling to revert back to initial homeostatic conditions (Crimins et al. 2012). Another 
key difference between fan cell and stellate cells is the way their dendrites distribute. 
Both cells distribute dendrites into layers I and II, but stellate cells also have dendrites 
that extend towards layer III (Tahvildari and Alonso, 2005). Wang and Mandelkow, 2016 
mention that a plausible mechanism for the spreading of tau pathology involves trans-
synaptic spreading. If true, stellate cells would be more vulnerable to this mechanism due 
to their dendritic arbor being more equally distributed throughout layers I, II, and III, 
whereas fan cell dendrites branch in a more unidirectional manner through layers I and II 
towards the pia, subsequently exposing fan cells to less neuronal interactions (Tahvildari 
and Alonso, 2005). 
Overall, this study found a notable response in terms of alterations of dendrite 
morphology to tau pathogenicity when comparing fan and stellate cells. For future 
studies, it might be useful to further explore the concept that spine density may be able to 
promote dendritic atrophy by analyzing spine density in neurons to see if neurons with a 
high or low density of spines might be resistant to dendritic atrophy commonly seen in 
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tauopathies. Additionally, attempting to map out an neuronal networks to establish the 
degree to which neurons are connected might make it feasible to test the concept if trans-
synaptic spreading might promote tauopathy and potentially dendritic morphological 
alterations. Third, although tau is critical in altering dendritic morphology due to its 
interaction with the neuronal cytoskeleton, stress granules also have been shown to 
interact with tau, since tauopathies have been shown to increase stress granule density. 
Therefore, by downregulating an RNA-binding protein such as TIA-1, it would be 
interesting to see if this altered the ability for stress granule aggregation to occur, and if 
this might alleviate some of the morphological pathologies affecting dendrite 
morphology.  
Understanding the entorhinal cortex is a crucial stepping stone for better 
understanding neurodegenerative diseases such as AD, which causes such a high burden 
on the individuals and families impacted by the disease. It is hopeful that as a better 
understanding of how tauopathies cause damage to neurons, therapeutic concepts can be 
designed to treat the earliest regions impacted by AD.  
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